These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27539378)

  • 1. Refractory OCD Due to Thalamic Infarct With Response to Dronabinol.
    Cooper JJ; Grant J
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):77-78. PubMed ID: 27539378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in refractory obsessive compulsive disorder with dronabinol.
    Schindler F; Anghelescu I; Regen F; Jockers-Scherubl M
    Am J Psychiatry; 2008 Apr; 165(4):536-7. PubMed ID: 18381920
    [No Abstract]   [Full Text] [Related]  

  • 3. Orbito-frontal cortex and thalamus volumes in obsessive-compulsive disorder before and after pharmacotherapy.
    Atmaca M; Mermi O; Yildirim H; Gurok MG
    Brain Imaging Behav; 2016 Sep; 10(3):669-74. PubMed ID: 26311393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory obsessive-compulsive disorder with symptoms regressing after thalamic infarction: A case report.
    Erbay LG; Erbay MF; Kamışlı S; Demirbay S; Ünal S
    Neurol India; 2022; 70(1):399-401. PubMed ID: 35263927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Australas Psychiatry; 2013 Apr; 21(2):117-21. PubMed ID: 23426097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study in patients with obsessive-compulsive disorder treated with electrical stimulation in the inferior thalamic peduncle.
    Jiménez-Ponce F; Velasco-Campos F; Castro-Farfán G; Nicolini H; Velasco AL; Salín-Pascual R; Trejo D; Criales JL
    Neurosurgery; 2009 Dec; 65(6 Suppl):203-9; discussion 209. PubMed ID: 19934996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Kimura S
    Clin Neuropharmacol; 2011; 34(6):260-1. PubMed ID: 22104637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
    Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders.
    Jiménez F; Nicolini H; Lozano AM; Piedimonte F; Salín R; Velasco F
    World Neurosurg; 2013; 80(3-4):S30.e17-25. PubMed ID: 22824558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial sonography in obsessive-compulsive disorder.
    Mavrogiorgou P; Nalato F; Meves S; Luksnat S; Norra C; Gold R; Juckel G; Krogias C
    J Psychiatr Res; 2013 Nov; 47(11):1642-8. PubMed ID: 23932243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder associated with a left orbitofrontal infarct.
    Kim KW; Lee DY
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):88-9. PubMed ID: 11884667
    [No Abstract]   [Full Text] [Related]  

  • 12. Approaches to the patient with treatment-refractory obsessive compulsive disorder.
    Jenike MA
    J Clin Psychiatry; 1990 Feb; 51 Suppl():15-21. PubMed ID: 2404966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ; Goodman WK; Leckman JF; Price LH
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive behavior therapy for obsessive-compulsive and related disorders.
    Lewin AB; Wu MS; McGuire JF; Storch EA
    Psychiatr Clin North Am; 2014 Sep; 37(3):415-45. PubMed ID: 25150570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P; Hegerl U
    MMW Fortschr Med; 1999 Sep; 141(39):32-4, 37. PubMed ID: 10897982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of obsessive compulsive disorders.
    Jenike MA
    Psychiatr Clin North Am; 1992 Dec; 15(4):895-919. PubMed ID: 1461804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine for blepharospasm, obsessive-compulsive symptoms, and psychotic symptoms in a patient of old brain infarction.
    Sun CH; Lu CH; Huang TL
    Clin Neuropharmacol; 2006; 29(6):368-70. PubMed ID: 17095902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-life reactivation of obsessive-compulsive disorder associated with lesions in prefrontal-subcortical circuits.
    Salinas C; Dávila G; Berthier ML; Green C; Lara JP
    J Neuropsychiatry Clin Neurosci; 2009; 21(3):332-4. PubMed ID: 19776315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyper-influence of the orbitofrontal cortex over the ventral striatum in obsessive-compulsive disorder.
    Abe Y; Sakai Y; Nishida S; Nakamae T; Yamada K; Fukui K; Narumoto J
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1898-905. PubMed ID: 26395293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.